We are thrilled to highlight a study on the genetics of idiopathic pulmonary fibrosis (IPF), recently published in The Lancet Respiratory Medicine by Team Telomere and Uplifting Athletes’ very own 2026 Young Investigator Draft Pick, Dr. Da (David) Zhang!

The full extent of genetic variants and causes that lead to IPF remain a mystery. By performing genetic analysis on data from over 4,600 IPF patients and 400,000+ controls across three independent cohorts, Dr. Zhang and colleagues investigated whether genetic variants that cause short telomeres also cause IPF, and clarified how different genetic variants impact an individual’s risk of developing IPF.

The key findings of the paper are that:

• Genetic variants that shorten telomeres increase IPF risk in multiple ways and across different patient groups
• IPF is not just one genetic disease – there are several paths that lead to the same disease

Dr. Zhang’s research underlies the crucial role of telomere length in IPF risk, and the discovery that there are distinct genetic pathways to IPF paves the way for precision diagnostics and targeted treatments tailored to each patient’s genetic profile. 

Congratulations, Dr. Zhang, on this important contribution to understanding and ultimately treating IPF! 🧬

Read more on our partnership with Uplifting Athletes: https://teamtelomere.org/resources/upliftingathletes/

Read the full paper: https://www.thelancet.com/journals/lanres/article/PIIS2213-2600(25)00405-9/fulltext